# Low Dose Statins, Ezetimibe and Nutraceuticals

Study · id `cardio:ct-nct03277079` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03277079](<https://clinicaltrials.gov/study/NCT03277079>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03277079

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03277079. Randomized; single masking; primary purpose treatment. Start 2017-10-01 (anticipated); primary completion 2017-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03277079, source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)
- Planned start: 2017-10-01 (anticipated) (ClinicalTrials.gov record NCT03277079, source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)
- Primary completion: 2017-12-31 (anticipated) (ClinicalTrials.gov record NCT03277079, source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)
- Completion: 2018-03-31 (anticipated) (ClinicalTrials.gov record NCT03277079, source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT03277079, source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03277079-2017-09-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low Dose Statins, Ezetimibe and Nutraceuticals
- Acronym: TACO
- Condition: Coronary Artery Disease
- Intervention (Drug): statin + ezetimibe
- Intervention (Drug): statin + ezetimibe + Nutraceuticals
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment (`cardio:pubmed-30420184`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6de1dfe27fc153ffb9f3c69dc3513fffc58d547b20c899b27e2f1049b963e8f2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
